Literature DB >> 9049681

Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation.

L M Tsai1, L J Lin, J K Teng, J H Chen.   

Abstract

The prevalence and clinical significance of left atrial thrombus were prospectively investigated in a consecutive series of 219 patients with chronic nonrheumatic atrial fibrillation using transesophageal echocardiography. Fifteen left atrial thrombi were detected in 15 of the 219 patients (6.8%); 12 of these thrombi (80%) were confined to the left atrial appendage. Left atrial spontaneous echo contrast was visualized in 85 patients (39%). All the thrombi were found in the left atria with spontaneous echo contrast. Patients with left atrial thrombus had significantly lower left ventricular ejection fraction than those without (49 +/- 14% vs. 59 +/- 14%; P < 0.05). Multivariate analysis among clinical and transthoracic echocardiographic variables showed that left ventricular ejection fraction < 50% was the only independent predictor for the presence of left atrial thrombus. A history of thromboembolism was significantly more frequent in patients with left atrial thrombus than in those without (73% vs. 32%; P < 0.005). The presence of left atrial thrombus was more specific than spontaneous echo contrast for predicting history of thromboembolism (97% vs. 80%), but its sensitivity was significantly lower (14% vs. 73%). We conclude that: (1) Transesophageal echo-detected left atrial thrombus is not uncommon in patients with chronic nonrheumatic atrial fibrillation and is exclusively observed in those with left atrial spontaneous echo contrast. (2) Impaired left ventricular systolic function may predispose the left atrial thrombus formation. (3) Left atrial thrombus is a highly specific but insensitive predictor for thromboembolic events.

Entities:  

Mesh:

Year:  1997        PMID: 9049681     DOI: 10.1016/s0167-5273(96)02862-8

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran.

Authors:  Yasutsugu Nagamoto; Tetsuya Shiomi; Taku Matsuura; Arihide Okahara; Kaoru Takegami; Daigo Mine; Takaharu Shirahama; Yasuaki Koga; Keiki Yoshida; Kenji Sadamatsu; Kiyoshi Hayashida
Journal:  Heart Vessels       Date:  2013-09-05       Impact factor: 2.037

2.  Patient characteristics and comorbidities associated with cerebrovascular accident following acute myocardial infarction in the United States.

Authors:  Nassim Naderi; Hossein Masoomi; Tahseen Mozaffar; Shaista Malik
Journal:  Int J Cardiol       Date:  2014-05-16       Impact factor: 4.164

Review 3.  Does Left Atrial Appendage Amputation During Routine Cardiac Surgery Reduce Future Atrial Fibrillation and Stroke?

Authors:  Helena Domínguez; Christoffer Valdorff Madsen; Oliver Nøhr Hjorth Westh; Peter Appel Pallesen; Christian Lildal Carrranza; Akhmadjon Irmukhamedov; Jesper Park-Hansen
Journal:  Curr Cardiol Rep       Date:  2018-08-31       Impact factor: 2.931

4.  Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation.

Authors:  Tetsuya Watanabe; Yukinori Shinoda; Kuniyasu Ikeoka; Tomoko Minamisaka; Hidetada Fukuoka; Hirooki Inui; Shiro Hoshida
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.